Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Kanada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. XPhyto Therapeutics Corp.
  6. News
  7. Andere Sprachen
    XPHY   CA98421R1055

XPHYTO THERAPEUTICS CORP.

(XPHY)
  Bericht
Verzögert CANADIAN NATIONAL STOCK EXCHANGE  -  18:19 23.09.2022
0.4050 CAD   -1.22%
20.09.XPHYTO THERAPEUTICS CORP. : XPhyto reicht Patentanmeldung für seine Datenbank neuartiger psychedelischer Wirkstoffe ein
DP
20.09.XPhyto Therapeutics Corp. reicht Patentanmeldung für Bibliothek neuartiger psychedelischer Verbindungen ein
CI
27.08.XPhyto Therapeutics Corp. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2022
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenDerivateFonds 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über XPHYTO THERAPEUTICS CORP.
20.09.XPhyto Therapeutics Corp. Files Patent Application for Library of Novel Psychedelic Com..
02.09.XPhyto Therapeutics Corp. announced that it has received CAD 3.6 million in funding
27.08.XPhyto Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Month..
04.08.XPhyto Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placemen..
23.07.XPHYTO THERAPEUTICS : Statement of Executive Compensation for financial year ended Decembe..
22.07.XPhyto Therapeutics Corp. announced that it expects to receive CAD 3.6 million in fundi..
18.07.Xphyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Tes..
18.07.XPHYTO THERAPEUTICS CORP. : XPhyto Pursues Potential Application of its Oral Dissolvable B..
28.06.XPhyto Therapeutics Corp. - Prof. Dr. Raimar Loebenberg receives Leadership Award from ..
08.06.Xphyto Therapeutics Corp. Adds Dr. Flon A. Sahr to Its European Teateam as Head of Proj..
01.06.XPHYTO THERAPEUTICS : Management's Discussion and Analysis for the First Quarter Ended Mar..
01.06.XPHYTO THERAPEUTICS : Interim Financial Statements for the First Quarter Ended March 31, 2..
27.05.XPhyto Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31..
09.05.XPhyto Therapeutics Corp. Reports Product Developments on Platform-Based Rotigotine Tra..
29.04.XPhyto Therapeutics Corp. Auditor Raises 'Going Concern' Doubt
29.04.XPhyto Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31,..
22.04.XPhyto Therapeutics Corp. announced that it has received CAD 2.3 million in funding
04.04.XPHYTO THERAPEUTICS : Reports Market and Product Developments on Platform-based Rotigotine..
01.04.XPHYTO THERAPEUTICS : Closes First Tranche of Financing
25.03.XPhyto Therapeutics Corp. announced that it expects to receive CAD 3 million in funding
22.02.XPhyto Therapeutics Corp.
09.02.XPhyto Therapeutics Reports on its Three Primary Business Divisions
02.02.XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies in German..
01.02.Xphyto Therapeutics Corp. Announces Sales Contract with Test Clinic and Pharmacies in G..
01.02.XPhyto Therapeutics Corp.
24.01.XPhyto Therapeutics Corp.
17.01.XPhyto Therapeutics Corp. Appoints Drahoslav Zdarek as the Company's Head of Sales, Eur..
17.01.XPhyto Signs Distribution Agreement for Czech Republic, Rollout Planned for Hungary, Sl..
17.01.XPhyto Therapeutics Corp.
10.01.XPhyto Therapeutics Corp.
10.01.XPhyto Therapeutics Corp. Announces Executive Appointments
2021XPhyto Therapeutics Corp.
2021XPHYTO THERAPEUTICS CORP. : XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Propri..
2021XPhyto Therapeutics Corp. Announces XPhyto Epilepsy Clinical Trial Plans in 2022 with I..
2021XPhyto Therapeutics Corp.
2021XPHYTO THERAPEUTICS CORP. : XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
2021XPhyto Therapeutics Corp. completed the acquisition of 3a-diagnostics GmbH.
2021XPHYTO THERAPEUTICS : Interim MD&A
2021XPHYTO THERAPEUTICS : Interim Financial Report
2021XPhyto Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Month..
2021XPhyto Therapeutics Corp. announced that it has received CAD 7 million in funding
2021XPhyto Therapeutics Corp. Announces Executive Changes
2021XPhyto Therapeutics Corp. Announces Management Changes
2021XPhyto Therapeutics Corp. announced that it expects to receive CAD 7.5 million in fundi..
2021XPHYTO THERAPEUTICS : Reports Development Update for its Drug Delivery Business
2021XPhyto Therapeutics Corp. Announces Development Update for Its Drug Delivery Business
2021XPHYTO THERAPEUTICS CORP : .
2021XPHYTO THERAPEUTICS : Reports Successful Market Launch and Growing Demand for its 25-minut..
2021XPhyto Therapeutics Corp. Announces the Successful Market Launch of Its 25-Minute COVID..
2021Xphyto Therapeutics Corp. Successfully Registered Their First Biosensor Test in Oral In..
2021Xphyto Therapeutics Corp. Reports Earnings Results for the Second Quarter Ended June 30..
2021XPHYTO THERAPEUTICS : acquisition target 3a-diagnostics reports breakthrough identificatio..
2021XPHYTO THERAPEUTICS CORP : . Bionity- XPhyto signs transformative acquisition agreement wi..
2021XPHYTO THERAPEUTICS CORP : .
2021XPhyto Therapeutics Corp. s signed a definitive agreement to acquire 3A-Diagnostics Gmb..
2021XPhyto Therapeutics Corp. Signs A Master Supply Agreement with Beovita GmbH & Co. KG an..
2021XPHYTO THERAPEUTICS : Down Although Supplies 10 Test Centers in Berlin with 25-minute COVI..
2021InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring ..
2021XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Rep..
2021XPHYTO THERAPEUTICS : Provides Progress Report on Mescaline Program for Psychedelic Therap..
2021XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
2021XPhyto Therapeutics Corp. Reports Earnings Results for the First Quarter Ended March 31..
2021XPHYTO THERAPEUTICS : Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
2021Max Pharma GmbH to Launch the Sale of 25-minute SARS-CoV- 2 (COVID-19) RT-PCR test syst..
2021XPhyto Therapeutics Corp. Provides Update on Drug Formulation and Development Business
2021XPhyto Therapeutics Corp. Establishes Proof of Concept Station for Point-Of-Care 25-Min..
2021XPhyto Therapeutics Corp Commences Pilot Project with its Rapid COVID-19 PCR Test
2021XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
2021XPhyto Therapeutics Corp. Auditor Raises 'Going Concern' Doubt
2021Xphyto Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31,..
2021XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-1..
2021XPhyto Therapeutics Corp. Appoints Wolfgang Probst as the Chief Operations Officer
2021XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European App..
2021MARIJUANA STOCKS BRIEF : Includes Agrify; Cardiol Therapeutics; GrowGeneration; GTEC Holdi..
2021MARIJUANA STOCKS BRIEF : This Quarter, 11 Constituents Were Added to HMMJ's Portfolio
2021MARIJUANA STOCKS BRIEF : Horizons ETFs Management (Canada) Inc. Completed Quarterly Rebala..
2021XPHYTO THERAPEUTICS CORP. : XPhyto announces European Approval for 25 Minute COVID-19 PCR ..
2021XPhyto Therapeutics Corp. and 3a-diagnostics GmbH Announces European Approval for 25 Mi..
2021EMERGING MARKETS REPORT : A Psychedelic Story
2021XPHYTO THERAPEUTICS CORP. : XPhyto Completes Corporate Rebranding and Launches New Website
2021EMERGING MARKETS REPORT : Rapid Results
2021XPhyto Therapeutics Corp. Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Te..
2021XPhyto Therapeutics Corp. Places First Order for 25-Minute Covid-19 RT-PCR Tests
2021XPHYTO THERAPEUTICS CORP. : XPhyto Places First Order for 25-Minute Covid-19 RT-PCR Tests
2021Xphyto Builds Commercial Team to Launch 25-Minute COVID-19 RT-PCR TEST
2021XPHYTO THERAPEUTICS CORP. : XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-P..
2021XPhyto European CE-IVD Application for 25-Minute COVID-19 RT-PCR Test
2021XPHYTO THERAPEUTICS CORP. : XPhyto Adds Mescaline Production to Psychedelic Medicine Progr..
2021XPHYTO THERAPEUTICS CORP. : XPhyto Announces Psychedelic Pharmaceutical Production Agreeme..
2021XPHYTO THERAPEUTICS : Down More than 14% After Providing Comments on Promotional Activity
2021XPhyto Therapeutics Corp. announced that it has received CAD 2.85 million in funding
2021XPhyto Therapeutics Corp. announced that it expects to receive CAD 2.85 million in fund..
2020XPhyto Therapeutics Corp. Completes Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Va..
2020XPhyto Therapeutics Corp. announced that it has received CAD 3 million in funding
2020XPhyto Therapeutics Corp. announced that it expects to receive CAD 3 million in funding
2020Xphyto Therapeutics Corp. Reports Earnings Results for the Third Quarter Ended Septembe..
2020Xphyto Therapeutics Corp. Announces It Has Expands Its Exclusive Development Agreement
2020XPhyto Therapeutics Corp. Appoints Per S. Thoresen to the Board of Directors
2020XPhyto Therapeutics Corp. Announces Update on Oral Thin Film Drug Delivery Programs
2020Rapid Screening Tests Are Still Struggling to Keep up with Demand
Anstehende Termine für XPHYTO THERAPEUTICS CORP.